National Health (Pharmaceutical Benefits Early Supply) Amendment Instrument 2015 (No. 10) specification under subsection 84AAA(2) (PB 110 of 2015) (Cth)

PB 110 of 2015

National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 10) – specification under subsection 84AAA(2)

National Health Act 1953

I, PENNY SHAKESPEARE, First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health, delegate of the Minister for Health, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

Dated 25^th November 2015

PENNY SHAKESPEARE

First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health

___________________________________________________________________________

Amendment determination – Pharmaceutical Benefits – Early Supply

1          Name of Instrument

(1)      This Instrument is the National Health (Pharmaceutical Benefits – Early Supply) Amendment Instrument 2015 (No. 10) – specification under subsection 84AAA(2).

(2)This Instrument may also be cited as PB 110 of 2015.

2          Commencement

This Instrument commences on 1 December 2015.

3          Amendment of PB 30 of 2009

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009 – specification under subsection 84AAA(2) (PB 30 of 2009).

Schedule 1        Amendments

1. Schedule 1, after entry for Aclidinium

insert:

Aclidinium with eformoterol Powder for oral inhalation in breath actuated device containing aclidinium 340 micrograms (as bromide) with eformoterol fumarate dihydrate 12 micrograms per dose, 60 doses Inhalation by mouth 1 5 1

1. Schedule 1, after entry for Tiotropium

insert:

Tiotropium with olodaterol Solution for oral inhalation containing tiotropium 2.5 micrograms (as bromide monohydrate) with olodaterol 2.5 micrograms (as hydrochloride) per dose, 60 doses Inhalation by mouth 1 5 1